发明名称 |
Combination therapy for reducing the risks associated with cardiovascular disease |
摘要 |
The present invention involves a combination therapy of administering a cholesterol reducing agent, such as a 3-hydroxy-3-methylglutaryl coenzyme a (HMG-CoA) reductase inhibitor and a platelet aggregation inhibitor for treating, preventing or reducing the risk of developing cardiovascular and cerebrovascular events and disorders in a mammal.
|
申请公布号 |
US6235706(B1) |
申请公布日期 |
2001.05.22 |
申请号 |
US19990147858 |
申请日期 |
1999.05.27 |
申请人 |
MERCK & CO., INC. |
发明人 |
GOULD ROBERT J.;NICHTBERGER STEVEN A.;RHYMER PATRICIA A.;OLOFSSON LARS |
分类号 |
A61K45/06;(IPC1-7):A61K38/00;A61K31/21;A61K31/35 |
主分类号 |
A61K45/06 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|